Cover Image
市場調查報告書

Ioversol的中國市場

Investigation Report on Chinese Ioversol Market, 2018-2022

出版商 China Research and Intelligence 商品編碼 338989
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Ioversol的中國市場 Investigation Report on Chinese Ioversol Market, 2018-2022
出版日期: 2018年07月05日 內容資訊: 英文 30 Pages
簡介

Ioversol為非離子系的顯影劑,由於毒性很低對人體沒有影響,用於影像診斷時的血管造影。隨著X光掃描、CT、超音波、MRI檢驗的利用數量增加,含Ioversol的血管顯影劑市場正在急速擴大。中國國內的Ioversol的銷售額,2005年為3000萬人民幣,2014年為2億人民幣,以27%年複合成長率(CAGR) 增加。

本報告提供中國的Ioversol的市場相關分析、Ioversol的特徵和認證情形、市場整體規模、各企業/各劑型的市場佔有率、價格趨勢、主要製造商簡介、今後的市場成長預測等調查評估。

第1章 Ioversol的相關概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國的Ioversol市場簡介

  • 中國國內的Ioversol的專利申請、核準情況
  • 主要製造商
  • 市場規模

第3章 中國國內的Ioversol銷售額分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 Ioversol的主要廠商的市場佔有率 (過去5年份)

  • 市場佔有率 (以金額為準)
  • 市場佔有率 (以數量為準)

第5章 中國國內的Ioversol的劑型 (過去5年份)

  • 各劑型的市場佔有率 (以金額為準)
  • 各劑型的市場佔有率 (以數量為準)

第6章 中國醫院的Ioversol的參照價格

  • Jiangsu Hengrui Medicine Co., Ltd
  • Mallinckrodt Medical Inc. (加拿大)
  • Mallinckrodt Medical Inc. (美國)

第7章 中國國內的Ioversol的主要製造商 (過去5年份)

  • Jiangsu Hengrui Medicine Co., Ltd
  • Mallinckrodt Medical Inc. (美國)

第8章 中國國內的Ioversol市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境的預測

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1806300

Description

Contract media are chemical products that are injected into or taken by human tissues or organs to improve image observation. The global contrast media market is growing continuously with higher demand for medical exam accuracy and increasing popularity of angiography.

Ioversol is a new-type non-ionic contrast agent mainly used in contrast-enhanced vascular imaging, featured by high contract density, avirulence, high tolerance and few side effects. After Ioversol is injected to blood vessels, the high proportion of iodine can cause x-ray attenuation and clearly show the blood vessels till Ioversol is diluted.

Contrast media are among the most common drugs in interventional radiology practice. They are mainly used to show blood vessels and coeloms. With large growth momentum and potential, the applications of contrast media have gradually extended from x-ray photography/CT scan imaging to diagnoses and examinations such as ultrasonography and magnetic resonance angiography. Ioversol has been widely used in China. As the number of the diagnosed continues to rise, the Ioversol market will continue to grow in China.

With China's growing demand for Ioversol, the sales value exceeded CNY 400 million in 2017. According to CRI, Jiangsu Hengrui, Liebel-Flarsheim and Mallinckrodt accounted for the major shares of the Chinese Ioversol market. By sales value, the market share of Jiangsu Hengrui exceeded 90% in 2017.

Topics Covered:

  • Development history of Ioversol in China
  • Size of China Ioversol market
  • Competition Pattern of Chinese Ioversol market
  • Prices in the Chinese Ioversol market
  • Prospects of Chinese Ioversol Market, 2018-2022

Table of Contents

Table of Contents

1 Relevant Concepts of Ioversol

  • 1.1 Indications
  • 1.2 Development History of Ioversol in China
  • 1.3 Production Permit of Ioversol in China

2 Investigation on Sales of Ioversol in China, 2013-2017

  • 2.1 Sales Value of Ioversol in China
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value in Different Regions
  • 2.2 Sales Volume of Ioversol in China
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume in Different Regions
  • 2.3 Sales of Ioversol in Different Dosage Forms in China
    • 2.3.1 Market Share of Ioversol in Different Dosage Forms by Sales Value
    • 2.3.2 Market Share of Ioversol in Different Dosage Forms by Sales Volume

3 Investigation on Market Share of Major Ioversol Manufacturers in China, 2013-2017

  • 3.1 Analysis on Market Competition of Ioversol in China, 2013-2017
    • 3.1.1 Major Manufacturers
    • 3.1.2 Market Share by Sales Value
    • 3.1.3 Market Share by Sales Volume
  • 3.2 Jiangsu Hengrui Medicine Co., Ltd.
    • 3.2.1 Profile of Jiangsu Hengrui Medicine Co., Ltd.
    • 3.2.2 Sales of Jiangsu Hengrui's Ioversol
    • 3.2.3 Sales Price of Jiangsu Hengrui's Ioversol
  • 3.3 Liebel-Flarsheim
  • 3.4 Mallinckrodt

4 Prospects of Chinese Ioversol Market, 2018-2022

  • 4.1 Forecast on Market Size
  • 4.2 Forecast on Competition Pattern

Selected Charts

  • Chart Production Permit of Ioversol in China
  • Chart Sales of Ioversol in China
  • Chart Sales Value of Ioversol in China, 2007-2017
  • Chart Sales Value of Ioversol in Parts of China, 2013-2017
  • Chart Sales Volume of Ioversol in China, 2007-2017
  • Chart Sales Volume of Ioversol in Parts of China, 2013-2017
  • Chart Market Share and Sales Value of Jiangsu Hengrui's Ioversol in China, 2013-2017
  • Chart Market Share and Sales Value of Liebel-Flarsheim's Ioversol in China, 2013-2017
  • Chart Market Share and Sales Value of Mallinckrodt's Ioversol in China, 2013-2017
  • Chart Sales Value and Market Share of Ioversol Injections in China, 2013-2017
  • Chart Prices of Jiangsu Hengrui's Ioversol in Several Chinese Cities, 2017-2018
  • Chart Prices of Mallinckrodt's Ioversol in Several Chinese Cities, 2017-2018
  • Chart Forecast on Ioversol's Sales in China, 2018-2022
Back to Top